Germ-Line Alterations in MSR1 Gene and Prostate Cancer Risk

Clinical Cancer Research

Volumn 9, Issue 14, 2003, Pages 5252-5256

  Seppälä, Eija H ^a,c   Ikonen, Tarja ^a   Autio, Ville ^b   Rökman, Annika ^a   Mononen, Nina ^a   Matikainen, Mika P ^b   Tammela, Teuvo L J ^b   Schleutker, Johanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 8P; CONTROLLED STUDY; FINLAND; GENE; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERM LINE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MSR1 GENE; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; COHORT STUDIES; FAMILY; FINLAND; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; RISK FACTORS; SCAVENGER RECEPTORS, CLASS A;

EID: 0242442016     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nwosu, V., Carpten, J., Trent, J. M., and Sheridan, R. Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum. Mol. Genet., 10: 2313-2318, 2001.
2. Tavtigian, S. V., Simard, J., Teng, D. H., Abtin, V., Baumgard, M., Beck, A., Camp, N. J., Carillo, A. R., Chen, Y., Dayananth, P., Desrochers, M., Dumont, M., Farnham, J. M., Frank, D., Frye, C., Ghaffari, S., Gupte, J. S., Hu, R., Iliev, D., Janecki, T., Kort, E. N., Laity, K. E., Leavitt, A., Leblanc, G., McArthur-Morrison, J., Pederson, A., Penn, B., Peterson, K. T., Reid, J. E., Richards, S., Schroeder, M., Smith, R., Snyder, S. C., Swedlund, B., Swensen, J., Thomas, A., Tranchant, M., Woodland, A. M., Labrie, F., Skolnick. M. H., Neuhausen, S., Rommens, J., and Cannon-Albright, L. A. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet., 27: 172-180, 2001.
3. Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J., Faruque, M., Moses, T., Ewing, C., Gillanders, E., Hu, P., Bujnovszky, P., Makalowska, I., Baffoe-Bonnie, A., Faith, D., Smith, J., Stephan, D., Wiley, K., Brownstein, M., Gildea, D., Kelly, B., Jenkins, R., Hostetter, G., Matikainen, M., Schleutker, J., Klinger, K., Connors, T., Xiang, Y., Wang, Z., De Marzo, A., Papadopoulos, N., Kallioniemi, O. P., Burk, R., Meyers, D., Gronberg, H., Meltzer, P., Silverman, R., Bailey-Wilson, J., Walsh, P., Isaacs, W., and Trent, J. Germline mutations in the ribonuclease L gene in families showing linkage with HPCl. Nat. Genet., 30: 181-184, 2002.
4. Rebbeck, T. R., Walker, A. H., Zeigler-Johnson, C., Weisburg, S., Martin, A. M., Nathanson, K. L., Wein, A. J., and Malkowicz, S. B. Association of HPC2/ELAC2 genotypes and prostate cancer. Am. J. Hum. Genet., 67: 1014-1019, 2000.
5. Rokman, A., Ikonen, T., Seppala, E. H., Nupponen, N., Autio, V., Mononen, N., Bailey-Wilson, J., Trent, J., Carpten, J., Matikainen, M. P., Koivisto, P. A., Tammela, T. L., Kallioniemi, O. P., and Schleutker, J. Germline alterations of the RNASEL gene, a candidate HPCl gene at 1q25, in patients and families with prostate cancer. Am. J. Hum. Genet., 76: 1299-1304, 2002.
6. Wang, L., McDonnell, S. K., Elkins, D. A., Slager, S. L., Christensen, E., Marks, A. F., Cunningham, J. M., Peterson, B. J., Jacobsen, S. J., Cerhan, J. R., Blute, M. L., Schaid, D. J., and Thibodeau, S. N. Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res., 61: 6494-6499, 2001.
7. Xu, J., Zheng, S. L., Carpten, J. D., Nupponen, N. N., Robbins, C. M., Mestre, J., Moses, T. Y., Faith, D. A., Kelly, B. D., Isaacs, S. D., Wiley, K. E., Ewing, C. M., Bujnovszky, P., Chang, B., Bailey-Wilson, J., Bleecker, E. R., Walsh, P. C., Trent, J. M., Meyers, D. A., and Isaacs, W. B. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am. J. Hum. Genet., 68: 901-911, 2001.
8. Camp, N. J., and Tavtigian, S. V. Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. Am. J. Hum. Genet., 71: 1475-1478, 2002.
9. Xu, J., Zheng, S. L., Hawkins, G. A., Faith, D. A., Kelly, B., Isaacs, S. D., Wiley, K. E., Chang, B., Ewing, C. M., Bujnovszky, P., Carpten, J. D., Bleecker, E. R., Walsh, P. C., Trent, J. M., Meyers, D. A., and Isaacs, W. B. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am. J. Hum. Genet., 69: 341-350, 2001.
10. Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J., Sterling, D., Lange, E. M., Hawkins, G. A., Turner, A., Ewing, C. M., Faith, D. A., Johnson, J. R., Suzuki, H., Bujnovszky, P., Wiley, K. E., DeMarzo, A. M., Bova, G. S., Chang, B., Hall, M. C., McCullough, D. L., Partin, A. W., Kassabian, V. S., Carpten, J. D., Bailey-Wilson, J. E., Trent, J. M., Ohar, J., Bleecker, E. R., Walsh, P. C., Isaacs, W. B., and Meyers, D. A. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat. Genet., 32: 321-325, 2002.
11. Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Chang, B., Turner, A. R., Ewing, C. M., Wiley, K. E., Hawkins, G. A., Bleecker, E. R., Walsh, P. C., Meyers, D. A., and Isaacs, W. B. Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am. J. Hum. Genet., 72: 208-212. 2003.
12. Wiklund, F., Jonsson, B. A., Goransson, I., Bergh, A., and Gronberg, H. Linkage analysis of prostate cancer susceptibility: confirmation of linkage at 8p22-23. Hum. Genet., 112: 414-418, 2003.
13. Emi, M., Asaoka, H., Matsumoto, A., Itakura, H., Kurihara, Y., Wada, Y., Kanamori, H., Yazaki, Y., Takahashi, E., Lepert, M., and et al. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J. Biol. Chem., 268: 2120-2125, 1993.
14. Gough, P. J., Greaves, D. R., and Gordon, S. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J. Lipid Res., 39: 531-543, 1998.
15. Matsumoto, A., Naito, M., Itakura, H., Ikemoto, S., Asaoka, H., Hayakawa, I., Kanamori, H., Aburatani, H., Takaku, F., Suzuki, H., and et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA, 87: 9133-9137, 1990.
16. El Khoury, J., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., and Loike, J. D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature (Lond.), 382: 716-719, 1996.
17. Platt, N., and Gordon, S. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. J. Clin. Investig., 108: 649-654, 2001.
18. Schleutker, J., Matikainen, M., Smith, J., Koivisto, P., Baffoe-Bonnie, A., Kainu, T., Gillanders, E., Sankila, R., Pukkala, E., Carpten, J., Stephan, D., Tammela, T., Brownstein, M., Bailey-Wilson, J., Trent, J., and Kallioniemi, O. P. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin. Cancer Res., 6: 4810-4815, 2000.
19. Syvanen, A. C. Solid-phase minisequencing as a tool to detect DNA polymorphism. Methods Mol. Biol., 98: 291-298, 1998.
20. De Marzo, A. M., Marchi, V. L., Epstein, J. I., and Nelson, W. G. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am. J. Pathol., 155: 1985-1992, 1999.
21. Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., and Thompson, T. C. Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res., 60: 5857-5861, 2000.
22. Peltonen, L., Palotie, A., and Lange, K. Use of population isolates for mapping complex traits. Nat. Rev. Genet., 1: 182-190, 2000.
23. Schleutker, J., Baffoe-Bonnie, A. B., Gillanders, E., Kainu, T., Jones, M. P., Freas-Lutz, D., Markey, C., Gildea, D., Riedesel, E., Albertus, J., et al. Genome-wide scan for linkage in Finnish hereditary prostate cancer families identifies novel susceptibility loci at 11q14 and 3p25-26. Prostate, in press.